Crystallized bovine serum albumin (Lot BX6, Pentex, Inc., Kankakee, Illinois) was used to induce the uveitis. A solution of 50 mg/ml in 0.85 per cent NaC1 was filtered through a Seitz filter, tested for sterility, and frozen in aliquots at -20°C for use as needed.
Mter anesthetizing the rabbit with nembutal and ether, both eyes were gently massaged for a short while to achieve hypotony. Each eye was then injected with 0.15 ml of the antigen solution into the vitreous. The injection was made slowly at the region of the upper equator with a 27-gange needle. The amount of material lost was slight, if any.
6-MP (Burroughs, Wellcome and Co., Inc., Tuckahoe, New York) at 50 mg/ml was dissolved in 0.85 per cent NaC1 containing 4 ml of 10 N NaOH/100 ml. The drug was given daily by deep intramuscular injections into the hind limbs for 14 days at a dose of 5 mg/kg body weight commencing on the day that the albumin was injected intraocularly. Control animals were given similar injections intramuscularly of the same diluent, without 6-MP.
The eyes were examined in the gross, and with the slit lamp. The uveitis was classified 0 through 5 based on the following criteria: 0, normal 1, trace iris hyperemia, no other changes. 2, mild iris injection, trace flare and ciliary flush. 3, moderate iris hyperemia; moderate amount of flare with ceils and precipitate over lens and cornea. 4, large amount of iris hyperemia; flare evident in the gross; fibrin and cells abundant; vitreous opacities present. 5, extreme iris hyperemia with miotic pupil, intense photophobia, and lacrimation; extensive fibrin deposition and cellular precipitates; dense vitreous opacities seen when the interior of the eye could be observed. Eyes were observed prior to the experiment, several hours after injection, and daily throughout the experiment. Both eyes of each animal were graded, and in most cases the degree of uveitis was the same. Photographs of the eyes were taken at appropriate intervals.
Control sera and aqueous samples were obtained 1 day prior to antigen administration. Blood samples were then collected from the ear artery on the 5th, 9th, 14th, 21st, and 30th day after intraocular albumin injection. Aqueous fluid was withdrawn from the left eye only on similar days. Sera were heat-inactivated at 57°C for 30 minutes, and then absorbed with an equal volume of washed packed sheep red blood cells. The aqueous fluid was studied directly. The degree of uveitis was not usually affected by the paracenteses. Protein determinations on the aqueous and sera were done by absorption measurements at 280 and 260 mg wavelengths, and the concentration estimated according to Kalckar. (13) The ratios were typical for proteins.
The antibody titers of both fluids were determined using the hemagglutination technic of Boyden (14) , a~s modified by Wide and Gemze]l (16) for use with formalin-fixed sheep red blood cells. Determination of residual antigen in the aqueous and vitreous was done by the hemaggiutination-inhibition technic. (15) Globes were removed at various intervals, fixed with 10 per cent formalin, embedded in paraffin, sectioned in the horizontal plane, and stained with hematoxylin and eosin for histologic study. Representative eyes were selected for microscopic examination.
RESULTS
Following the injection of bovine serum albumin intraocular|y, a mild, temporary, rapidly developing, inflammatory reaction was produced in both the treated and control rabbits. This reaction occurred several hours after injection, remained for I or 2 days, and was presumed to be due to the trauma of injection. There appeared to be no difference in the severity of the reaction between the treated and the control group of rabbits.
During the 5th to 9th days, the eyes of the untreated group of rabbits developed a spontaneous inflammatory allergic reaction of varying degrees. This reaction reached a peak in 2 to 3 days and cleared slowly so that by the 15th day, most eyes were normal in the gross. The earlier the onset, the more severe and prolonged the inflammation tended to be. All of the twenty-seven control rabbits which were followed past the 9th day developed a uveitis of varying severity. On the other hand, during the 14 days of treatment, most of the thirty rabbits given 6-MP showed little or no ocular inflammation. Nine rabbits showed a mild uveitis, while only one rabbit developed a 3+ response. The remaining twenty showed no detectable reaction. Comparison of the clinical results in the two groups are summarized in Table I . These data represent the maximum uveitis which occurred at any time after the injection and up to 14 days. Photographs at various intervals were obtained to document the clinical course. Fig. 1 depicts the appearance of representative eyes of the two groups 12 days after intraocular antigen injection. Following cessation of therapy with 6-MP, it was of interest that eight rabbits revealed either an increased degree of previously existing uveitis or the appearance of a mild inflammation within 4 to 6 days. By the end of the 30 days all eyes were quiet. The time relationship of the clinical events in the two groups is summarized in Text- fig. 1 . The days charted were chosen as being most illustrative of the course of disease. Serum antibody titers against bovine serum albumin were determined and the results are given in Text- fig. 2 . The sera of control animals showed a prompt rise to high titers within 9 days. In several rabbits, antibodies could be detected as early as the 5th day. By the 14th day titers were maximum and remained elevated during the course of the experiment. Animals treated with 6-MP showed a striking suppression of antibody titer in the serum. By the 14th day of treatment, eight animals revealed no detectable serum antibodies, and the rest displayed low levels. Following cessation of the drug a slow but increasing titer of antibody appeared in the sera.
The titers in aqueous fluid generally paralleled those in the serum (see Text- fig. 3 ). However, the appearance of antibodies in the aqueous was not as 
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Tgxr-Fm. 1. Suppression of the clinical course of uveitis by 6-MP. BSA injected on day 0. The degree of uveitis (0 to Sq-) is that described in the text. Note the marked uveitis on day 9 in the control as compared to the treated group. Each point represents one animal.
prompt. Analysis of Text-figs. 1 to 3 reveals that there is a general correlation between the rise of serum and aqueous antibody titers, and the development of ocular inflammation in both groups.
The maximum degree of uveitis developing during the first 14 days (the period of 6-MP administration), and the antibody titers in the sera are compared in Text- fig. 4 . It will be seen that treated animals showed little or no uveitis and low serum antibody titers. The control animals revealed a greater degree of inflammation and this was generally associated with high serum antibody titer levels. A titer of 1:64 in this system appeared to represent a critical level of antibody associated with severe uveitis.
Determination of residual antigen in the vitreous and aqueous revealed that bovine serum albumin could be detected in these specimens prior to the appearance of antibodies. The concentration of residual antigen was inversely proportional to the length of time after injection. Generally no antigen could be detected in either the control or treated groups after the 14th day.
There was a large variation in protein values among the aqueous samples and this could be roughly correlated with the intensity of uveitis at the time of Animals treated with 6-MP revealed similar inflammatory responses but they were less severe and were delayed in onset and course. One eye on the 9th day which clinically revealed beginning uveitis, displayed the typical histologic findings of a mild iridocyclitis much like that seen in the control rabbits. Large lymphocytes, monocytes, and undifferentiated mononuclear cells were evident in the ciliary processes, iris, and over the optic nerve head. The specimens of two eyes on the 14th day revealed normal anterior segments and vitreous. The only significant finding was a mild infiltration of the optic nerve head with nests of deeply stained mononuclear cells, essentially small lymphocytes, and monocytes. Scattered polymorphs and early plasma cells were occasionally seen. Sections taken on the 21st day resembled those seen on the 14th day. However, MAXIMUM UVEITIS 0-14 DAYS T~.x~-Fm. 4. A graph relating the maximum degree of uveitis to maximum sera antibody taters during the initial 14 days of the experiment (the time of 6-MP administration). Note that rabbits which developed the more severe uveifis displayed titers of 64 or greater. Each point represents one animal.
the ciliary processes and choroid showed a scattered infiltration with small lymphocytes. Two specimens were obtained on the 30th day. One revealed a normal anterior segment but with mild infiltration of the choroid with nests of small deeply staining cells, presumably lymphocytes. The other eye displayed a mild uveifis affecting the ciliary body, choroid, and optic nerve head. Lymphocytes and monocytes predominated but plasma cells and large undifferentiated mononuclear cells were also seen. Fig. 2 illustrates some of these findings.
To determine whether 6-MP alone had any significant effect on the eye, three rabbits as another control were treated with 6-MP for 14 days. 0.15 ml of isotonic saline was injected into the left eye of each rabbit; the right eye was untouched. The gross clinical course and the histologic picture revealed no effect on normal eye structures.
TABLE II

Comparison of Aqueous Fluid Findings in the Control and Treated Animals
Degree of uveitis is that recorded at time of paracentesis. Rabbits arranged in descending order of severity of uveitis. The samples were obtained from individual animals on different days during the course of the disease, and do not necessarily represent the maximum degree of uveitis which developed. 24  2048  256  2+  22  1024  512  2+  12  512  512  1+  18  4096  2048  1+  13  1024  1024  1+  4  64  128  1+  1  512  256  0  13  256  1024  0  5  256  512  0  3  64  64  0  3  128  256  0  3  64  128  0  2  16  8  0  1  4  8  128  64 
DISCUSSION
These experiments clearly demonstrated that 6-MP will inhibit the appearance of allergic uveitis following a single intraocular injection of bovine serum albumin in rabbits. These findings were evident both at the clinical and histological levels. The results appear to be due to interference with the immune response since a good correlation was demonstrated between the antibody titers and the height of uveitis in both the control, and 6-MP animals during the period of treatment.
Following cessation of drug therapy a rise in antibody titer occurred but this was not usually accompanied by an apparent or significant degree of uveitis.
It may be that an insufficient amount of residual antigen was present to initiate the allergic reaction.
The treated animals revealed a slow rise of serum antibody titer when 6-MP was discontinued, but at the termination of the experiment a significant difference in the titers of the two groups was still clearly evident. Since the antigen doses were the same, it might be expected that comparable final serum antibody titers would be seen. The most likely explanation, again, is that insufficient residual antigen was present to further stimulate antibody production.
There is no evidence in this experiment to suggest an anti-inflammatory action of 6-MP. Using steroids, Fernando (18) was able to inhibit the appearance of uveitis in a similar experimental situation. However, he also noted that steroids suppressed the initial non-specific inflammatory response associated with the trauma of injection. Animals treated with 6-MP in this experiment revealed no significant difference in the clinical picture or histologic findings of the initial reaction to the trauma of injection when compared to the control group.
The aqueous protein determinations revealed a significantly lower content in treated animals. There was a rough correlation between the degree of uveitis and the protein content in all animals studied. Inasmuch as 6-MP did not alter serum protein levels, it was felt that the lower aqueous protein values merely reflected the inhibition of the allergic uveifis, and was not due to any specific effect of the drug on the aqueous metabolism. The findings of lower protein content in the treated group served as a further check on the clinical evidence that 6-MP suppressed the allergic uveitis.
The histologic findings also bore out the clinical findings that 6-MP suppressed the inflammatory allergic response. The tissue changes that appeared during the course of therapy were less marked than those observed in the controls. During treatment many eyes showed no uveitis at all. Following cessation of therapy the microscopic findings were either normal or those of a low grade uveitis, at a time when control specimens were showing resolution. At the termination of the experiment, control eyes revealed no inflammatory exudate, while treated specimens revealed a delay in the appearance of the uveitis and also, consequently, in its healing. It is important to point out that the specific cellular response and its manner of distribution in tissues of the eye were similar in both groups.
It is interesting to speculate on the significance that these findings may have in the treatment of human uveitis. It has been presumed that ocular hypersensitivity plays an important role in the pathology of both granulomatous and non-granulomatous uveitis. In the former instance, the lesions are believed due to both the invading pathogen and the hypersensitivity that develops to products of the organism. In the latter instance no specific organisms have been incrimated, but hypersensitivity phenomena are believed to be involved.
Non-specific treatment of the human disease has been limited almost exclusively to the use of corticosteroids. These drugs owe their effect in large part to an anti-inflammatory action. (5) However, in certain situations they suppress immune responses in large doses. On the basis of the studies reported here, an evaluation of drugs like 6-MP which primarily inhibit antibody formation might be indicated for the treatment of certain forms of uveifis.
Pyrimethamine (daraprim), a drug which is known to exert a toxoplasmacidal effect, has been used extensively in the treatment of toxoplasma uveitis. However, pyrimethamine is a folic acid antagonist, and in experimental animals this compound has been shown to suppress antibody formation. (6) It may well be that part of the beneficial effects seen in treatment of this disease may be due to the latter effect of suppressing antibody formation. Studies to determine this action of pyrimethamine are being carried out. FI6. 2 f. Mild inflammatory response in the optic nerve head in a 6-MP-treated rabbit. 14 days after antigen injection.
